What is Altimmune's restricted cash?

Altimmune (ALT) reported restricted cash of $42K in Q1 2026.

How has Altimmune's restricted cash changed year-over-year?

Altimmune's restricted cash decreased by 0.0% year-over-year, from $42K to $42K.

What is the long-term trend for Altimmune's restricted cash?

Over 5 years (2020 to 2025), Altimmune's restricted cash has grown at a 4.2% compound annual growth rate (CAGR), from $34.17K to $42K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Altimmune ALT Restricted Cash

Restricted Cash at other companies

Merck & Co.MRK

$71M-31.1%

Madrigal Pharmaceuticals, Inc.MDGL

$5.16M+3.1%

Wave Life SciencesWVE

$3.82M+1.1%

MeiraGTx Holdings plcMGTX

$2.22M+6.2%

Mirum Pharmaceuticals, Inc.MIRM

$1.73M+308%

Alumis Inc.ALMS

$86K-92.6%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's restricted cash?: Altimmune (ALT) reported restricted cash of $42K in Q1 2026.
How has Altimmune's restricted cash changed year-over-year?: Altimmune's restricted cash decreased by 0.0% year-over-year, from $42K to $42K.
What is the long-term trend for Altimmune's restricted cash?: Over 5 years (2020 to 2025), Altimmune's restricted cash has grown at a 4.2% compound annual growth rate (CAGR), from $34.17K to $42K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.